Next report date
Report period
Q1 2024
EPS estimate
−0.39USD
Revenue estimate
—
−1.45USD
−19.77 MUSD
15.48 M
About MAIA Biotechnology, Inc.
Sector
Industry
CEO
Vlad Vitoc
Website
Headquarters
Chicago
Employees (FY)
13
Founded
2018
FIGI
BBG0113Q7J88
MAIA Biotechnology, Inc. is a clinical stage biotechnology company that is engaged in the discovery, development and commercialization of therapies targeting cancer. Its product, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded on August 3, 2018 and is headquartered in Chicago, IL.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MAIA is 2.94 USD — it has increased by 9.70% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange MAIA Biotechnology, Inc. stocks are traded under the ticker MAIA.
MAIA Biotechnology, Inc. is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.
MAIA stock is 13.16% volatile and has beta coefficient of 1.19. Check out the list of the most volatile stocks — is MAIA Biotechnology, Inc. there?
MAIA earnings for the last quarter are −0.36 USD per share, whereas the estimation was −0.39 USD resulting in a 6.49% surprise. The estimated earnings for the next quarter are −0.39 USD per share. See more details about MAIA Biotechnology, Inc. earnings.
Yes, you can track MAIA Biotechnology, Inc. financials in yearly and quarterly reports right on TradingView.
MAIA stock has risen by 50.77% compared to the previous week, the month change is a 13.95% rise, over the last year MAIA Biotechnology, Inc. has showed a 31.84% increase.
MAIA net income for the last quarter is −6.26 M USD, while the quarter before that showed −4.88 M USD of net income which accounts for −28.32% change. Track more MAIA Biotechnology, Inc. financial stats to get the full picture.
No, MAIA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MAIA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MAIA Biotechnology, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 13.00 employees. See our rating of the largest employees — is MAIA Biotechnology, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MAIA Biotechnology, Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MAIA Biotechnology, Inc. stock shows the strong buy signal. See more of MAIA Biotechnology, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MAIA Biotechnology, Inc. future price: according to them, MAIA price has a max estimate of 14.00 USD and a min estimate of 14.00 USD. Read a more detailed MAIA Biotechnology, Inc. forecast: see what analysts think of MAIA Biotechnology, Inc. and suggest that you do with its stocks.